โ† Back

Adcendo ๐Ÿ‡ฉ๐Ÿ‡ฐ

Series C

Copenhagen biotech developing first-in-class antibody-drug conjugates for cancer

About Adcendo

Adcendo is a Denmark-based company founded in 2017, now around 66 people. FundFinder classes it as Health & Bio.

Founded by Henrik Stage (Founder; previously CHOSA Oncology, Carlsberg Group; Copenhagen Business School), Niels Behrendt (Founder; University of Copenhagen).

Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.

Want the latest on Adcendo? Our research agent pulls the current description, latest round and full investor base from public sources (about a minute).

Series C ยท Apr 2026

InvestorsHealthCap
  • HealthCap โ€” HealthCap is a life sciences venture investor and company creator based in Stockholm and founded in 1996.

Series B ยท $135M ยท Nov 2024

InvestorsHealthCap

Read the announcement โ†—

Funding history

Nov 2024Series B ยท $135MHealthCap
Apr 2026Series CHealthCap

โ— rounds tracked in this directory ยท โ—‹ earlier rounds web-verified from public announcements. Amounts as announced; undisclosed rounds omitted.

Raising your own round? See which European funds fit โ†’